Credit Suisse’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $673K | Buy |
36,281
+331
| +0.9% | +$6.14K | ﹤0.01% | 2489 |
|
|
2023
Q4 | $584K | Buy |
35,950
+429
| +1% | +$6.97K | ﹤0.01% | 2646 |
|
|
2023
Q3 | $491K | Sell |
35,521
-3,632
| -9% | -$50.2K | ﹤0.01% | 2689 |
|
|
2023
Q2 | $865K | Buy |
39,153
+10,535
| +37% | +$233K | ﹤0.01% | 2473 |
|
|
2023
Q1 | $622K | Buy |
28,618
+9
| +0% | +$196 | ﹤0.01% | 2607 |
|
|
2022
Q4 | $521K | Sell |
28,609
-1,587
| -5% | -$28.9K | ﹤0.01% | 2741 |
|
|
2022
Q3 | $687K | Buy |
30,196
+6,737
| +29% | +$153K | ﹤0.01% | 2575 |
|
|
2022
Q2 | $323K | Buy |
23,459
+2,460
| +12% | +$33.9K | ﹤0.01% | 3106 |
|
|
2022
Q1 | $477K | Buy |
20,999
+1,392
| +7% | +$31.6K | ﹤0.01% | 2995 |
|
|
2021
Q4 | $732K | Buy |
19,607
+1,488
| +8% | +$55.6K | ﹤0.01% | 2788 |
|
|
2021
Q3 | $767K | Buy |
18,119
+2,429
| +15% | +$103K | ﹤0.01% | 2748 |
|
|
2021
Q2 | $698K | Sell |
15,690
-4,023
| -20% | -$179K | ﹤0.01% | 2835 |
|
|
2021
Q1 | $709K | Sell |
19,713
-4,286
| -18% | -$154K | ﹤0.01% | 2762 |
|
|
2020
Q4 | $957K | Buy |
+23,999
| New | +$957K | ﹤0.01% | 2608 |
|
|
2016
Q3 | – | Sell |
-220,548
| Closed | -$352K | – | 3732 |
|
|
2016
Q2 | $352K | Hold |
220,548
| – | – | ﹤0.01% | 3318 |
|
|
2016
Q1 | $404K | Sell |
220,548
-19
| -0% | -$35 | ﹤0.01% | 3069 |
|
|
2015
Q4 | $478K | Buy |
220,567
+19
| +0% | +$41 | ﹤0.01% | 3197 |
|
|
2015
Q3 | $466K | Hold |
220,548
| – | – | ﹤0.01% | 3248 |
|
|
2015
Q2 | $430K | Hold |
220,548
| – | – | ﹤0.01% | 3544 |
|
|
2015
Q1 | $356K | Hold |
220,548
| – | – | ﹤0.01% | 3491 |
|
|
2014
Q4 | $362K | Hold |
220,548
| – | – | ﹤0.01% | 3576 |
|
|
2014
Q3 | $464K | Buy |
220,548
+110,274
| +100% | +$232K | ﹤0.01% | 3306 |
|
|
2014
Q2 | $251K | Buy |
+110,274
| New | +$251K | ﹤0.01% | 3800 |
|